Adir J, Miller A K, Vestal R E
Clin Pharmacol Ther. 1982 Apr;31(4):488-93. doi: 10.1038/clpt.1982.65.
Tolbutamide plasma protein binding at different total tolbutamide concentrations was determined in 44 healthy, nonsmoking, drug-free men from 23 to 87 yr old. The data showed that unbound drug increased with total tolbutamide plasma concentration and with age, but that neither the binding equilibrium constant nor the number of binding sites correlated with age. The increase in unbound fraction with age could be partially explained by the decrease in albumin concentration in elderly subjects. Results of multiple linear regression analysis indicated that, although age had a considerably greater influence than albumin concentration, total tolbutamide concentration was the most important determinant of the unbound fraction. Thus, both age and total plasma concentration may affect tolbutamide kinetics.
在44名年龄在23至87岁之间、健康、不吸烟且未服用药物的男性中,测定了不同甲苯磺丁脲总浓度下的甲苯磺丁脲血浆蛋白结合率。数据显示,游离药物随甲苯磺丁脲血浆总浓度和年龄的增加而增加,但结合平衡常数和结合位点数量均与年龄无关。老年受试者白蛋白浓度降低可部分解释游离分数随年龄增加的现象。多元线性回归分析结果表明,虽然年龄的影响比白蛋白浓度大得多,但甲苯磺丁脲总浓度是游离分数的最重要决定因素。因此,年龄和血浆总浓度均可能影响甲苯磺丁脲的动力学。